| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 02/12/2014 | EP2694475A1 Hydroxyphenyl pyrrole compounds containing an hydroxamic acid as hdac inhibitors and medicinal applications thereof |
| 02/12/2014 | EP2694474A1 4r,5r-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity |
| 02/12/2014 | CN103582496A Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom |
| 02/12/2014 | CN103570601A Preparation method of optical active medicine intermediate |
| 02/12/2014 | CN103570576A Regeneration system and regeneration method for circulating solvent of cracked C5 separation device |
| 02/12/2014 | CN102786458B Pyrrole formamide derivative, and preparation method and application thereof |
| 02/12/2014 | CN102617436B Preparation method for 2-(2-oxo-pyrrolidyl) butanamide |
| 02/12/2014 | CN102089277B Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing same |
| 02/11/2014 | US8648193 Dinitroxide-type biradical compounds optimized for dynamic nuclear polarization (DNP) |
| 02/11/2014 | US8648110 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
| 02/11/2014 | US8648109 Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium |
| 02/11/2014 | CA2288330C Benzoyl amino acid derivatives useful as inhibitors of protein isoprenyl tranferases |
| 02/06/2014 | WO2014021281A1 Partially saturated nitrogen-containing heterocyclic compound |
| 02/06/2014 | WO2014020462A1 Improved process for preparation of vildagliptin intermediate |
| 02/06/2014 | US20140038979 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/06/2014 | US20140038943 Serotonin receptor modulator |
| 02/06/2014 | US20140038934 Modulators of serotonin receptors |
| 02/05/2014 | EP2691368A1 Pyrrole derivatives as nicotinic acetylcholine receptor modulators for use in the treatment of neurodegenerative disorders such as alzheimer's and parkinson's disease |
| 02/05/2014 | CN103562218A Dominant negative hsp110 mutant and its use in prognosing and treating cancers |
| 02/05/2014 | CN103562181A Method for producing hemiaminal compound and method for producing cyanoamine compound |
| 02/05/2014 | CN103554001A High-selectivity preparation method of pyrrole compounds |
| 02/05/2014 | CN103554000A (S)-oxiracetam crystal form III, and preparation method and application thereof |
| 02/05/2014 | CN103553999A Preparation method of (S)-oxiracetam crystal form III |
| 02/05/2014 | CN103553998A Preparation method of (S)-oxiracetam crystal form III |
| 02/05/2014 | CN103553997A Preparation method of (S)-oxiracetam crystal form III |
| 02/05/2014 | CN103553996A Anticholinergic pharmaceutical composition |
| 02/05/2014 | CN102531989B Purification method for (S)-oxiracetam |
| 02/05/2014 | CN102344401B Method for preparing amorphous atorvastatin calcium |
| 02/04/2014 | US8642642 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| 02/04/2014 | US8642641 Co-crystals of pyrrolidinones |
| 02/04/2014 | US8642640 1-phenylpyrrole derivatives |
| 02/04/2014 | US8642628 Pyrrole inhibitors of S-nitrosoglutathione reductase |
| 02/04/2014 | US8642580 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and platinum derivatives |
| 02/04/2014 | CA2573969C Oxidative degradation products of atorvastatin calcium |
| 01/30/2014 | US20140031563 New compounds for inhibiting differentiation of osteoclast and pharmaceutical composition comprising thereof |
| 01/30/2014 | US20140031562 Method for Forming Allylic Alcohols |
| 01/30/2014 | US20140031549 Process and Intermediates for the Synthesis of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one Compounds |
| 01/30/2014 | US20140031398 Trpm8 receptor antagonists |
| 01/30/2014 | US20140031370 Amide derivatives, process for preparation thereof and use thereof as insecticide |
| 01/30/2014 | US20140031331 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 01/29/2014 | EP2690116A1 N-phenylmaleimide compound and copolymer composition obtained using same |
| 01/29/2014 | EP2688907A1 Dominant negative hsp110 mutant and its use in prognosing and treating cancers |
| 01/29/2014 | EP2688870A1 Heterocyclic amine derivatives |
| 01/29/2014 | CN1914224B HCV NS-3 serine protease inhibitors |
| 01/29/2014 | CN103547566A Aminoindane compounds and use thereof in treating pain |
| 01/29/2014 | CN103539716A One group of 2-para chlorphenyl-4-substituted methyl-5- trifluoromethyl-3-cyanpyrrole compounds |
| 01/29/2014 | CN102702060B Racemization recovery method for by-products in split mother liquor of Vernakalant intermediates |
| 01/29/2014 | CN102658206B Ruthenium-carbyne complex catalyst and preparation method and application thereof |
| 01/29/2014 | CN102304007B Asymmetric catalytic hydrogenation reaction method of intra-annular N-alkylimine |
| 01/29/2014 | CN101616893B Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists |
| 01/28/2014 | US8637611 Amide-extended crosslinking compounds and methods for use thereof |
| 01/28/2014 | US8637568 Serotonin reuptake inhibitors |
| 01/28/2014 | US8637546 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV) |
| 01/28/2014 | US8637534 Fungicide active substance combinations |
| 01/28/2014 | CA2631741C Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 01/28/2014 | CA2614193C Zofenopril calcium in polymorph form c |
| 01/28/2014 | CA2535265C Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 01/23/2014 | WO2014015247A1 Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions |
| 01/23/2014 | WO2014014050A1 1-(cycloalkyl-carbonyl)proline derivative |
| 01/23/2014 | WO2014012935A1 Substituted aminoindane- and aminotetralincarboxylic acids and use thereof |
| 01/23/2014 | US20140024696 Atropisomer of pyrrole derivative |
| 01/23/2014 | US20140024680 Insecticidal Arylpyrrolines |
| 01/23/2014 | US20140024679 Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives |
| 01/23/2014 | US20140024647 Aromatic heterocyclic derivative having trpv4-inhibiting activity |
| 01/22/2014 | EP2687513A1 Drugs for inhibiting aggregation of proteins invoved in diseases linked to protein aggregation and/or neurodegenerative diseases |
| 01/22/2014 | CN103534237A Insecticidal compounds based on arylthioacetamide derivatives |
| 01/22/2014 | CN103525453A Oxidative coupling extraction desulfurization of petroleum product as well as ionic liquid and preparation method thereof |
| 01/22/2014 | CN103524395A Synthesis methods of pyrrole acylhydrazone copper complex ligand and pyrrole acylhydrazone copper complexes |
| 01/22/2014 | CN103524394A Synthetic method and application of fluorine-containing azacyclo-alkyne liquid crystal compound |
| 01/22/2014 | CN103524372A Novel histone deacetylase inhibitor |
| 01/22/2014 | CN102603605B Preparation method of (S)-4-hydroxy-2-oxo-1-pyrrolidineacetamide |
| 01/22/2014 | CN102603604B Preparation method of (S)-4-hydroxy-2-oxo-1-pyrrolidine acetamide |
| 01/22/2014 | CN102603597B Preparation method of (S)-oxiracetam |
| 01/22/2014 | CN102224136B 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission |
| 01/21/2014 | US8633224 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 01/21/2014 | US8633221 Method of enhancing lysosomal α-galactosidase A |
| 01/21/2014 | US8633001 Process for producing optically active succinimide derivatives and intermediates thereof |
| 01/16/2014 | WO2014010611A1 Organic electroluminescence element and electronic apparatus |
| 01/16/2014 | WO2014010250A1 Asymmetric auxiliary group |
| 01/16/2014 | WO2013149035A3 N-acyl-amino acid derivatives for improvement of the flavour profile edible|compositions |
| 01/16/2014 | US20140018546 Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1) |
| 01/16/2014 | US20140018407 Crystalline form of a 3-phenoxymethylpyrrolidine compound |
| 01/16/2014 | US20140018327 Pyrrole Derivatives as Nicotinic Acetylcholine Receptor Modulators for Use in the Treatment of Neurodegenerative Disorders Such as Alzheimer's and Parkinson's Disease |
| 01/15/2014 | EP2684873A1 Drugs for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |
| 01/15/2014 | EP2684871A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 01/15/2014 | EP2683687A1 Primary amine diazeniumdiolate heterocyclic derivatives |
| 01/15/2014 | EP2683686A1 Method for producing primary amines obtained by homogeneously catalyzed alcohol amination |
| 01/15/2014 | CN203393060U Electronic-grade chemical reagent purification device |
| 01/15/2014 | CN103508932A Method for synthesizing diabetes drug-glimepiride |
| 01/15/2014 | CN103508931A Hexahydropentaleno derivatives, preparation methods and applications in medicine thereof |
| 01/15/2014 | CN103508930A Bis(aminodithioformate)-1,3-propane diester compound, and synthesis method, pharmaceutical composition and use thereof |
| 01/15/2014 | CN101668426B Smac mimetic dimers and trimers useful as anti-cancer agents |
| 01/14/2014 | US8629163 Tetrakis-quaternary ammonium salts and methods for modulating neuronal nicotinic acteylcholine receptors |
| 01/14/2014 | US8629084 Iodine-phenyl-substituted cyclic cetoenols |
| 01/14/2014 | US8628759 Soft anticholinergic esters |
| 01/14/2014 | CA2649650C Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 01/14/2014 | CA2602234C Histamine h3 receptor agents, preparation and therapeutic uses |
| 01/09/2014 | WO2014008350A1 Process for preparing bicyclic amine derivatives |
| 01/09/2014 | WO2014007398A1 Cationic lipid |
| 01/09/2014 | WO2014006629A1 Novel cholecystokinin receptor ligands |